Latest AI and machine learning research in chemotherapy for healthcare professionals.
Since the introduction of the Vesical Imaging-Reporting and Data System (VI-RADS), MRI has become an important imaging modality in the management of patients with bladder cancer. Its excellent diagnostic performance for determining muscle invasion in bladder cancer has been supported by numerous prospective and retrospective studies. Nevertheless, there needs to be continued improvement of the dia...
BACKGROUND AND OBJECTIVE: Neoadjuvant immune-checkpoint inhibitors (ICIs) in muscle-invasive bladder cancer (MIBC) were tested in patient's ineligible for cisplatin-based chemotherapy. The PURE-01 trial (NCT02736266) evaluated three courses of pembrolizumab before radical cystectomy (RC). We developed AI-MIRACLE, an international study assessing artificial intelligence (AI) and multiparametric mag...
Accurate assessment of lymph node metastasis (LNM) following neoadjuvant chemoradiotherapy (nCRT) presents a significant clinical challenge and is ess...
BACKGROUND: Mesenchymal stem cells (MSCs) secretome have shown promise in the treatment of alopecia areata (AA). However, the key therapeutic genes re...
Platinum-based high-entropy alloys (Pt-HEAs), composed of multiple principal elements in near-equiatomic ratios, have emerged as a transformative clas...
BACKGROUND: Neoadjuvant chemoradiotherapy (nCRT) is the standard treatment for locally advanced rectal cancer (LARC), yet clinically validated biomark...
BACKGROUND: Colorectal cancer (CRC) is a biologically heterogeneous disease in which tumor sidedness has emerged as a relevant prognostic factor. Conv...
INTRODUCTION: Biomarker-guided stratification is essential for optimizing adjuvant systemic therapy in early-stage breast cancer, requiring a balance ...
BACKGROUND: Predicting risk of cancer therapy-related cardiac dysfunction (CTRCD) remains challenging. OBJECTIVES: The purpose of this study was to as...
The role of SLC26A3 in the sensitivity to oxaliplatin, a widely used chemotherapy drug for colorectal cancer (CRC), remains unclear. This study aimed ...
BACKGROUND: Skin hyperpigmentation has attracted widespread attention. Traditional chemical skin-whitening components pose potential risks, whereas fo...
A critical issue for the hydrogen evolution reaction (HER) is to break the inherent trade-off between catalytic activity and mass/charge transport in ...
BACKGROUND: While expression-based signatures inform adjuvant therapy in breast cancer (BC), no approved molecular biomarkers exist for the neoadjuvan...
Cancer immunotherapy has revolutionised oncology by utilising immune-mediated mechanisms to achieve durable anti-tumour responses and long-term clinic...
Identifying image features that associate strongly with diagnostic or prognostic classes in large-scale, multi-channel spatial imaging is challenging ...
BACKGROUND: Osteosarcoma treatment decisions require accurate prognostic assessment, yet utilization of machine learning (ML) models is problematic be...
Adverse events (AEs) of small molecule kinase inhibitors (SMKIs) at therapeutic doses in cancer patients are largely unpredictable in phase I-III stud...
Neoadjuvant therapy is standard for locally advanced rectal cancer (LARC), yet regimen selection remains population-based, risking over- or undertreat...
BACKGROUND: Gemcitabine is an important chemotherapeutic agent that suffers from poor bioavailability and drug resistance. Although the nanocomposite ...
Influenza A viruses pose a significant pandemic threat, with H2N3 in particular representing a subtype of particular concern due to limited population...